Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mayu Yoshikawa
Phosphodiesterase 5 Inhibitor Is Effective Both CKD and Nephrotic Syndrome Models by Protecting Glomerular Filtration Barrier.
Proceedings for Annual Meeting of The Japanese Pharmacological Society
Related publications
Maintenance of Glomerular Filtration Barrier Integrity Requires Laminin 5
Journal of the American Society of Nephrology : JASN
Medicine
Nephrology
Glomerular Filtration Rate Trends During Follow-Up in Children With Steroid-Sensitive Nephrotic Syndrome
Canadian Journal of Kidney Health and Disease
Nephrology
Genetic Disorders of the Glomerular Filtration Barrier
Clinical Journal of the American Society of Nephrology
Epidemiology
Nephrology
Critical Care
Transplantation
Intensive Care Medicine
Glomerular Filtration Barrier and Molecular Segregation: Guilty as Charged?
Journal of the American Society of Nephrology : JASN
Medicine
Nephrology
ACE-inhibitor Induced Angioedema Masked by Nephrotic Syndrome
The Southwest Respiratory and Critical Care Chronicles
Confocal Super-Resolution Imaging of the Glomerular Filtration Barrier Enabled by Tissue Expansion
Kidney International
Nephrology
Aberrant Glomerular Filtration of Urokinase-Type Plasminogen Activator in Nephrotic Syndrome Leads to Amiloride-Sensitive Plasminogen Activation in Urine
American Journal of Physiology - Renal Physiology
Urology
Physiology
Attenuation of NADPH Oxidase Activation and Glomerular Filtration Barrier Remodeling With Statin Treatment
Hypertension
Internal Medicine
Cancer Therapy Combination: Green Tea and a Phosphodiesterase 5 Inhibitor?
Journal of Clinical Investigation
Medicine
